Pharma

Alloy Therapeutics Inks a Pact with Takeda to Develop Cell Therapy Platform

Alloy Therapeutics Inks a Pact with Takeda to Develop Cell Therapy Platform

Shots: Alloy Therapeutics has entered into a strategic collaboration and licensing...

Pharmanovia Collaborates with Lindis Biotech to Commercialize Catumaxomab for Treating Malignant Ascites

Pharmanovia Collaborates with Lindis Biotech to Commercialize Catumaxomab for Treating Malignant Ascites

Shots: Pharmanovia has entered into a new licensing agreement with Lindis Biotech...

Bayer Join Forces with Cytokinetics to Develop and Commercialize Aficamten in Japan

Bayer Join Forces with Cytokinetics to Develop and Commercialize Aficamten in Japan

Shots: Bayer and Cytokinetics have partnered to develop and commercialize aficamte...

Ratio Therapeutics Partners with Novartis to Advance SSTR2-Targeting Radiotherapeutic Candidate for Cancer

Ratio Therapeutics Partners with Novartis to Advance SSTR2-Targeting Radiotherapeutic Candidate for Cancer

Shots: Ratio Therapeutics has entered into an exclusive worldwide licensing and co...

Merck Join Forces with LaNova Medicines to Advance LM-299 for Advanced Solid Tumors

Merck Join Forces with LaNova Medicines to Advance LM-299 for Advanced Solid Tumors

Shots: Merck and LaNova Medicines have collaborated to develop the latter’s...

Nippon Shinyaku Collaborates with Atsena Therapeutics to Commercialize ATSN-101 Across the US and Japan

Nippon Shinyaku Collaborates with Atsena Therapeutics to Commercialize ATSN-101 Across the US and Japan

Shots: Nippon Shinyaku has signed an exclusive licensing agreement with Atsena to...

Image